Advertisement
Best practice advice statements from the American College of Physicians and the U.S. Centers for Disease Control and Prevention

Best Practice Advice Issued for Hep B Vaccination, Screening

0
All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk
For patients with unruptured intracranial aneurysms that are 3 mm or smaller

No Treatment or Imaging Follow-Up Most Effective for Tiny UIAs

0
Highest health benefit for unruptured intracranial aneurysms with no treatment or preventive follow-up
For patients with atrial fibrillation

NOACs Show Lower Risk of Adverse Renal Outcomes in A-Fib

0
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
Physicians who are experiencing burnout are more than twice as likely to leave their organization within two years

High Costs Associated With Physician Burnout, Attrition

0
Economic loss at Stanford over two years expected to range from $15.5 million to $55.5 million
Patients with injection drug use (IDU) endogenous endophthalmitis (EE) are younger

Distinct Features for Drug Use-Related Endophthalmitis

0
Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention
For children with concussion

Salivary miRNAs Can ID Duration of Concussion Symptoms

0
Pediatric patients with prolonged symptoms were accurately identified by levels of five miRNAs
For male and female high school students

Dating Violence Victimization, Nonmedical Rx Med Use Linked

0
Nonmedical use of prescription drugs linked to dating violence for male, female high school students
Overdosing of erlotinib may be associated with rapid onset of conjunctivitis

Erlotinib Overdose Tied to Conjunctivitis

0
Findings in case study of man being treated for non-small-cell lung cancer
Force-sensing bipolar forceps and force analysis may help differentiate surgeon skill level

Force Analysis May Help Distinguish Surgeon Skill Level

0
Force-sensing bipolar forceps can be used to measure force variables during neurosurgery
Hemlibra (emicizumab-kxwh) has been approved by the U.S. Food and Drug Administration to prevent or reduce the frequency of bleeding episodes among hemophilia A patients with Factor VIII inhibitors.

FDA OKs Drug for Hemophilia A With Factor VIII Inhibitors

0
Weekly prophylactic treatment associated with substantial decrease in bleeding episodes